$18.0M
+$18.0M this year1 filing since 2026 · latest Equity filed
Magnendo is an MIT spinout developing a robotic navigation system for neurovascular procedures such as stroke thrombectomy and brain aneurysm treatment. Its platform pairs magnetically steerable soft-robotic guidewires with robotic control, medical imaging and navigation software so physicians can reach clots in tortuous brain vasculature faster and more consistently. The technology derives from years of ferromagnetic soft robotics research at MIT, and the team includes engineers and physicians from MIT, Harvard Medical School and Massachusetts General Hospital. The company is preclinical and raised an $18M Series A led by Penumbra, Inc. to productize the platform and prepare first-in-human studies.
What sets it apart
Magnetic steering of a soft-robotic guidewire rather than mechanical push-and-torque, which lets the tip navigate complex cerebral vasculature that conventional guidewires cannot reach while reducing the risk of vessel perforation or dissection.
A telerobotic platform combining a magnetically steerable soft-robotic guidewire with robotic actuation, medical imaging and intelligent navigation software for endovascular access to the brain.
